Ospedale Ruber Internacional
| Turchia | Austria | Spagna | |
| Brachiterapia | da $3,465 | da $15,000 | da $10,000 |
| Brachiterapia per il tumore alla prostata | da $2,500 | da $9,000 | da $8,000 |
| Brachiterapia per il carcinoma uterino | - | - | da $3,987 |
Il medico è un esperto di fama mondiale in oncologia radioterapica, con un focus sul trattamento del cancro alla prostata. Specializzandosi in tecniche avanzate come Gammaknife, Cyberknife, SIRT e IMRT, il medico guida il Dipartimento di Oncologia Radioterapica al Centro Médico Teknon dal 1999.<\/p>
Con una formazione estesa in istituzioni prestigiose come l'Ospedale Universitario di Sant Pau, il Royal Marsden Hospital e il Laboratorio di Ciclotrone di Harvard, il medico possiede un dottorato in medicina e chirurgia dall'Università di Ginevra.<\/p>
Vincitore del Premio Varian per l'Oncologia Radioterapica, il medico ha scritto oltre 100 pubblicazioni scientifiche e collabora con il CERN in ricerche correlate.<\/p>
Head of Department of Vascular and Interventional Radiology
Spain offers high-precision brachytherapy through Joint Commission International accredited centers like Centro Médico Teknon and Hospital Ruber Internacional. Patients benefit from specialized multidisciplinary teams, advanced HDR and LDR technologies, and approximately 50% savings compared to average United States treatment costs for prostate cancer.
Bookimed Expert Insight: Spain’s oncology network is unique because clinics like Centro Médico Teknon serve elite global figures while maintaining high volume expertise, treating 10,000 patients annually. This massive scale allows Spanish centers to offer advanced HDR brachytherapy—which requires just 2 sessions—at $8,000, a price point rarely found in other European medical hubs for this level of technology.
Patient Consensus: Patients value how this tissue-sparing treatment preserves quality of life by reducing risks of incontinence and erectile dysfunction. The shorter hospital stays and targeted approach provide a less stressful experience than traditional surgery or external beam radiation.
Barcelona and Madrid are the premier cities for brachytherapy in Spain, hosting JCI-accredited facilities that specialize in high-dose-rate radiation. Barcelona excels in prostate cancer care at Centro Médico Teknon, while Madrid offers extensive radiotherapy networks like GenesisCare and top-tier oncology at Hospital Ruber Internacional.
Bookimed Expert Insight: While patients often choose Madrid or Barcelona for prestige, Clinica Universidad de Navarra in Pamplona frequently offers higher limb-preservation rates for complex cases. Our data shows this facility maintains a 95% limb preservation rate, making it a critical choice for sarcomas requiring precise internal radiation.
Patient Consensus: Many patients find that seeking centers with specific high-dose-rate capability is more vital than the city itself. They often highlight that Spain offers specialized outpatient-style planning, which significantly reduces the time spent in the hospital compared to US centers.